N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial

N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial

Abstract Background Epidemiological and clinical evidence suggests that high-dose intake of omega 3 fatty acids (n-3 FA) have a favorable role in altering serum triglycerides (TG) and non-high density lipoprotein cholesterol (non-HDL-C) when combined with statins in hyperlipidemic patients. Their ef...

Full description

Bibliographic Details
Main Authors: Gediz Dogay Us, Sohail Mushtaq
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Lipids in Health and Disease
Subjects:
Cardiovascular risk
Atherosclerosis
Hyperlipidemia
Lipoprotein
Low-density lipoprotein cholesterol size
Omega 3 polyunsaturated fatty acids
Online Access:https://doi.org/10.1186/s12944-022-01686-y

Internet

https://doi.org/10.1186/s12944-022-01686-y

Similar Items